UBS Maintains Neutral Rating on Healthcare Realty Trust, Cuts Price Target to $18
UBS lowered its price target to $18 per share from $21 while maintaining its Neutral rating.
UBS lowered its price target to $18 per share from $21 while maintaining its Neutral rating.